Literature DB >> 24368638

A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer.

Jin-Young Jang1, Mee Joo Kang, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Sang Jae Park, Sung-Sik Han, Dong Sup Yoon, Hee Chul Yu, Koo Jeong Kang, Sang Geol Kim, Sun-Whe Kim.   

Abstract

OBJECTIVE: To prospectively evaluate the survival benefit of dissection of the nerve plexus and lymphadenectomy in patients with pancreatic head cancer.
BACKGROUND: Despite randomized controlled trials on the extent of surgery in pancreatic cancer, attempts have been made to perform more extended resections.
METHODS: A total of 244 patients were enrolled; of these, 200 were randomized to undergo standard resection or extended resection, with the latter including the dissection of additional lymph nodes and the right half of the nerve plexus around the superior mesenteric artery and celiac axis. We evaluated 167 patients from 7 centers who fulfilled all of the required criteria. RESULT: Operation time was longer and estimated blood loss was higher in the extended resection group than in the standard resection group, but the R0 resection rate was comparable. The mean number of lymph nodes retrieved per patient was higher in the extended resection group than in the standard resection group (33.7 vs 17.3; P < 0.001). The morbidity rate was slightly higher in the extended resection group than in the standard resection group. Two patients in the extended resection group died in hospital. Median survival after R0 resection was similar in the extended resection and standard resection groups (18.0 vs 19.0 months; P = 0.239) regardless of lymph node metastasis. Adjuvant chemoradiation had a positive impact on overall survival.
CONCLUSIONS: This study suggests that extended lymphadenectomy with dissection of the nerve plexus does not provide a significant survival benefit compared with standard resection in pancreatic head cancer. Standard resection can be performed safely and efficiently, without negatively affecting oncologic efficacy or long-term survival, when compared with extended pancreaticoduodenal resection. (NCT00679913)?

Entities:  

Mesh:

Year:  2014        PMID: 24368638     DOI: 10.1097/SLA.0000000000000384

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  46 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients.

Authors:  Woohyun Jung; Jin-Young Jang; Mee Joo Kang; Ye Rim Chang; Yong Chan Shin; Jihoon Chang; Sun-Whe Kim
Journal:  HPB (Oxford)       Date:  2015-12-21       Impact factor: 3.647

Review 3.  A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma.

Authors:  Lorenzo A Orci; Jeremy Meyer; Christophe Combescure; Leo Bühler; Thierry Berney; Philippe Morel; Christian Toso
Journal:  HPB (Oxford)       Date:  2015-04-23       Impact factor: 3.647

4.  Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up.

Authors:  Stefano Andrianello; Salvatore Paiella; Valentina Allegrini; Marco Ramera; Alessandra Pulvirenti; Giuseppe Malleo; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2015-07-02       Impact factor: 3.445

Review 5.  Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Nadia Peparini
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

6.  Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety.

Authors:  Yosuke Inoue; Akio Saiura; Atsushi Oba; Shoji Kawakatsu; Yoshihiro Ono; Takafumi Sato; Yoshihiro Mise; Takeaki Ishizawa; Yu Takahashi; Hiromichi Ito
Journal:  J Gastrointest Surg       Date:  2018-10-10       Impact factor: 3.452

7.  Para-Aortic Dissection in Pancreaticoduodenectomy with Mesopancreas Excision for Pancreatic Head Carcinoma: Not Only an N-Staging Matter.

Authors:  Nadia Peparini
Journal:  J Gastrointest Surg       Date:  2016-03-21       Impact factor: 3.452

8.  Preoperative defining system for pancreatic head cancer considering surgical resection.

Authors:  Seok Jeong Yang; Ho Kyoung Hwang; Chang Moo Kang; Woo Jung Lee
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  Technical Details of an Anterior Approach to the Superior Mesenteric Artery During Pancreaticoduodenectomy.

Authors:  Yosuke Inoue; Akio Saiura; Masayuki Tanaka; Masaru Matsumura; Yoshinori Takeda; Yoshihiro Mise; Takeaki Ishizawa; Yu Takahashi
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

10.  Comparison of Surgical Outcomes Between Radical Antegrade Modular Pancreatosplenectomy (RAMPS) and Standard Retrograde Pancreatosplenectomy (SPRS) for Left-Sided Pancreatic Cancer.

Authors:  Toshiya Abe; Kenoki Ohuchida; Yoshihiro Miyasaka; Takao Ohtsuka; Yoshinao Oda; Masafumi Nakamura
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.